Malaria is a disease that knows no borders. Defeating it requires a variety of stakeholders to work together towards our common goal: the elimination of malaria in Asia by 2030. At the highest level, national governments, health organizations, and regional alliances coordinate to develop effective public health policies and programs. These policies optimise the use of human and financial resources, build stronger health systems, and support elimination programs in local communities where malaria is still a threat.
M2030 is a unique movement that adds the power of businesses and consumers to the fight against malaria. M2030 harnesses corporate leadership to advocate for action, and raise awareness and funds for malaria elimination programs. To maximize our impact, M2030 partners engage with policy makers, civil society and communities.
The Lancet Commission’s recent report on “Malaria eradication within a generation: ambitious, achievable, and necessary” acknowledges the unique contribution M2030 can bring. The report states that M2030’s “branded, business-led initiatives not only raise additional funds, but also engage businesses and business leaders as important advocates in the achievement of national and regional health goals.” In addition to fostering corporate leadership, M2030 can “bring knowledge and engagement to the general population who can contribute to malaria elimination through their purchasing choices.” The report also encourages regional alliances to support mobilization campaigns like M2030 because of the additional leadership and resources they can generate.
Another recent report on “Vector Control in the Indo-Pacific: Technical, Regulatory and Market-Access Landscapes” by the Innovative Vector Control Consortium described M2030 as a way to “accelerate the elimination of malaria and improve health outcomes.” The report said that M2030 “marks the first time that influential Asian-led businesses have united under the same brand to collaborate and champion the fight against malaria.”
M2030 also participates in the shaping and development of national malaria elimination policies. For example, M2030 partners participated in a two-day workshop in November 2019 in Yangon, Myanmar to feed into Myanmar’s next National Strategic Plan for Malaria (2021-2025). All Myanmar stakeholders in malaria elimination were present, including national ministries, UN agencies, Civil Society Organizations, the private sector, and human rights and gender groups. The National Strategic Plan recognized M2030 as an important driver of corporate leadership to fight malaria in Myanmar.
Eliminating malaria in Asia is a team effort. It is only achievable by 2030 if everyone works together. M2030 contributes by bringing leading businesses and consumers to this fight. As a new model of private sector engagement, M2030 is working hard to ensure that regional and national policies recognize the importance of inclusive partnerships for malaria elimination.